BRIEF-Helix Biopharma announces deal with National Research Council of Canada

Mon Jul 18, 2016 4:35pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 18 (Reuters) - Helix Biopharma Corp

* Helix Biopharma announces agreement in principle with National Research Council of Canada to collaborate on various immuno-oncology initiatives

* Agreement spells out framework to enable Helix to finalize master agreement with NRC to develop new therapeutics for cancer immunotherapies

* Agreement allows for discussion on a potential license of antibody previously obtained from NRC under a material transfer agreement Source text for Eikon: Further company coverage: